FDA Approves Generic Equivalent to Climara Pro Hormone Patch
1 report, 1 independent
Updated Oct 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The Food and Drug Administration approved the first generic version of Climara Pro on October 19, 2026. This generic patch was rated therapeutically equivalent to Bayer's Climara Pro. It is approved for women with an intact uterus to treat moderate to severe hot flashes and night sweats caused by menopause.
From medicaldaily.com
Why it matters
The approval introduces generic competition to the market for this combination hormone patch. Generic competition often leads to lower costs for patients. The patch delivers estradiol and levonorgestrel to treat menopausal symptoms and help prevent postmenopausal osteoporosis.
Generic medicine services are seeking approval for launch from the FDA.
From medicaldaily.com
Who's involved
- FDARegulatory agency that approved the generic equivalent of Climara Pro.
- Eli Lilly and CompanyThe FDA formally regulates Eli Lilly's drug development and market activities.